|
|
Article: ATCC Vero Cells Used To Manufacture Second Rotavirus Vaccine For Clinical Trials.
- Article from:
- Business Wire
- Article date:
- November 19, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MANASSAS, Va. -- ATCC (American Type Culture Collection) announced today that its master cell bank of highly characterized Vero cells will be used for the manufacture of a second promising rotavirus vaccine candidate.
The rotavirus vaccine candidate was developed by Murdoch Childrens Research Institute (MCRI) in Victoria, Australia. ATCC Vero cells will be used as substrates to grow the rotavirus strain that is being used in the vaccine.
Several features make ATCC's Vero master cell bank a desirable substrate for vaccine development and manufacture. The bank was started from Vero cells provided to ATCC in 1967, establishing a known pedigree and allowing ...